Table of Content


Introduction
Dyslipidemia - Overview
Dyslipidemia - Therapeutics Development
Dyslipidemia - Therapeutics Assessment
Dyslipidemia - Companies Involved in Therapeutics Development
Dyslipidemia - Drug Profiles
Dyslipidemia - Dormant Projects
Dyslipidemia - Discontinued Products
Dyslipidemia - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Dyslipidemia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Dyslipidemia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Target, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Dyslipidemia - Pipeline by 89bio Inc, H2 2020
Dyslipidemia - Pipeline by ABIONYX Pharma SA, H2 2020
Dyslipidemia - Pipeline by Acasti Pharma Inc, H2 2020
Dyslipidemia - Pipeline by AD Pharmaceuticals Co Ltd, H2 2020
Dyslipidemia - Pipeline by Affina Biotechnologies Inc, H2 2020
Dyslipidemia - Pipeline by Afimmune Biopharma Ltd, H2 2020
Dyslipidemia - Dormant Projects, H2 2020
Dyslipidemia - Discontinued Products, H2 2020